Search results for "MUTATION"

showing 10 items of 2830 documents

The

2016

ABSTRACT Members of the Junctophilin (JPH) protein family have emerged as key actors in all excitable cells, with crucial implications for human pathophysiology. In mammals, this family consists of four members (JPH1-JPH4) that are differentially expressed throughout excitable cells. The analysis of knockout mice lacking JPH subtypes has demonstrated their essential contribution to physiological functions in skeletal and cardiac muscles and in neurons. Moreover, mutations in the human JPH2 gene are associated with hypertrophic and dilated cardiomyopathies; mutations in JPH3 are responsible for the neurodegenerative Huntington's disease-like-2 (HDL2), whereas JPH1 acts as a genetic modifier …

NotchGenotypeCardiomyopathyGenes InsectAnimals Genetically ModifiedAnimalsDrosophila ProteinsAllelesMammalsNeuronsHuntingtin ProteinReceptors NotchMusclesMyocardiumMembrane ProteinsReproducibility of ResultsDrosHuntington's diseaseDisease Models AnimalDrosophila melanogasterPhenotypeGene Knockdown TechniquesMutationNerve DegenerationPhotoreceptor Cells InvertebrateRNA InterferenceJunctophilinDrosophilaTrinucleotide Repeat ExpansionSignal TransductionResearch ArticleDisease modelsmechanisms
researchProduct

Nuclear Data for the Thorium Fuel Cycle and the Transmutation of Nuclear Waste

2016

Neutron-induced reaction cross sections play an important role in a wide variety of research fields, ranging from stellar nucleosynthesis, the investigation of nuclear level density studies, to applications of nuclear technology, including the transmutation of nuclear waste, accelerator-driven systems, and nuclear fuel cycle investigations. Simulations of nuclear technology applications largely rely on evaluated nuclear data libraries. These libraries are based both on experimental data and theoretical models. An outline of experimental nuclear data activities at CERN’s neutron time-of-flight facility, n_TOF, will be presented.

Nuclear fuel cycleNuclear technologyStellar nucleosynthesisNuclear transmutationChemistryNuclear engineeringNuclear TheoryRadioactive wasteNuclear dataNeutronNuclear ExperimentThorium fuel cycle
researchProduct

Toward large-area targets for “TRAKULA”

2011

Abstract TRAKULA ( Tra nsmutationsrelevante k ernphysikalische U ntersuchungen l anglebiger A ktinide, i.e., nuclear physical investigations of long-lived actinides with relevance to transmutation) is a joint research project of the German Federal Ministry of Science and Education (BMBF) on nuclear physics investigations with modern scientific, technological and numerical methods. Experiments concerning the transmutation of radioactive waste are a central topic of the project. For this, large-area samples (≥40 cm 2 ) of 235,238 U and 239,242 Pu compounds are required for the calibration of fission chambers and for fission yield measurements. Another topic within the project requires large-a…

Nuclear physicsPhysicsNuclear and High Energy PhysicsNuclear transmutationFissionNuclear engineeringRadioactive wasteFission product yieldSurface finishActinideNeutron activation analysisInstrumentationElectrochemical cellNuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
researchProduct

Measurement of the 241Am neutron capture cross section at the n-TOF facility at CERN

2016

New neutron cross section measurements of minor actinides have been performed recently in order to reduce the uncertainties in the evaluated data, which is important for the design of advanced nuclear reactors and, in particular, for determining their performance in the transmutation of nuclear waste. We have measured the 241 Am(n,γ) cross section at the n TOF facility between 0.2 eV and 10 keV with a BaF2 Total Absorption Calorimeter, and the analysis of the measurement has been recently concluded. Our results are in reasonable agreement below 20 eV with the ones published by C. Lampoudis et al. in 2013, who reported a 22% larger capture cross section up to 110 eV compared to experimental …

Nuclear reactionNuclear transmutationnTOFQC1-999Neutron[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]01 natural sciences7. Clean energyNuclear physicsPhysics and Astronomy (all)Cross section (physics)Nuclear reactorsReactors nuclears0103 physical sciencesCERNNeutron cross sectionNuclear Physics - Experimentddc:530Neutron010306 general physicsAbsorption (electromagnetic radiation)PhysicsNeutrons:Energies::Energia nuclear [Àrees temàtiques de la UPC]Large Hadron ColliderCross section:Física [Àrees temàtiques de la UPC]010308 nuclear & particles physicsPhysicsNuclear reactionCalorimeter
researchProduct

Nuclear data activities at the n_TOF facility at CERN

2016

International audience; Nuclear data in general, and neutron-induced reaction cross sections in particular, are important for a wide variety of research fields. They play a key role in the safety and criticality assessment of nuclear technology, not only for existing power reactors but also for radiation dosimetry, medical applications, the transmutation of nuclear waste, accelerator-driven systems, fuel cycle investigations and future reactor systems as in Generation IV. Applications of nuclear data are also related to research fields as the study of nuclear level densities and stellar nucleosynthesis. Simulations and calculations of nuclear technology applications largely rely on evaluate…

Nuclear reactionU-235Nuclear transmutationnTOFCAPTURE CROSS-SECTIONNuclear dataTOTAL ABSORPTION CALORIMETERGeneral Physics and Astronomy[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]COLLABORATION7. Clean energy01 natural sciences3100PHYSICSNuclear physicsPhysics and Astronomy (all)neutronDESIGNRadiation dosimetry0103 physical sciencesCERNn_TOFNuclear Physics - ExperimentNeutron010306 general physicsnuclear data n_TOF CERNPhysics:Energies::Energia nuclear [Àrees temàtiques de la UPC]NeutronsFRAGMENT ANGULAR-DISTRIBUTIONLarge Hadron Colliderntof:Física [Àrees temàtiques de la UPC]Cross section010308 nuclear & particles physicscernExperimental dataRadioactive wasteNuclear datanuclear dataNATURAL SCIENCES. Physics.Radiació--DosimetriaPRIRODNE ZNANOSTI. Fizika.Nuclear technologyCAPTURE CROSS-SECTION TOTAL ABSORPTION CALORIMETER FRAGMENT ANGULAR-DISTRIBUTION NEUTRON TH-232 U-235 C6D6 COLLABORATION PHYSICS DESIGN.NEUTRONTH-232C6D6
researchProduct

Insights into mRNP biogenesis provided by new genetic interactions among export and transcription factors.

2012

Abstract Background The various steps of mRNP biogenesis (transcription, processing and export) are interconnected. It has been shown that the transcription machinery plays a pivotal role in mRNP assembly, since several mRNA export factors are recruited during transcription and physically interact with components of the transcription machinery. Although the shuttling DEAD-box protein Dbp5p is concentrated on the cytoplasmic fibrils of the NPC, previous studies demonstrated that it interacts physically and genetically with factors involved in transcription initiation. Results We investigated the effect of mutations affecting various components of the transcription initiation apparatus on the…

Nucleocytoplasmic Transport ProteinsSaccharomyces cerevisiae Proteinslcsh:QH426-470MutantActive Transport Cell NucleusRNA-binding proteinRNA polymerase IISaccharomyces cerevisiaeDEAD-box RNA HelicasesTranscription (biology)GeneticsGenetics(clinical)RNA MessengerNuclear poreMex67pTranscription factorGenetics (clinical)AllelesDbp5pGeneticsmRNA exportbiologyGeneral transcription factorfungiNuclear ProteinsRNA-Binding Proteinslcsh:GeneticsRibonucleoproteinsMutationbiology.proteinNuclear PoreRNA Polymerase IINuclear Pore ComplexTranscriptionBiogenesisTranscription FactorsResearch ArticleBMC genetics
researchProduct

Capping Parallel β-Sheets of Acetyl(Ala)6NH2 with an Acetyl(Ala)5ProNH2 Can Arrest the Growth of the Sheet, Suggesting a Potential for Curtailing Amy…

2014

We present ONIOM calculations using B3LYP/d95(d,p) as the high level and AM1 as the medium level on parallel β-sheets containing four strands of Ac-AAAAAA-NH2 capped with either Ac-AAPAAA-NH2 or Ac-AAAPAA-NH2. Because Pro can form H-bonds from only one side of the peptide linkage (that containing the C═O H-bond acceptor), only one of the two Pro-containing strands can favorably add to the sheet on each side. Surprisingly, when the sheet is capped with AAPAAA-NH2 at one edge, the interaction between the cap and sheet is slightly more stabilizing than that of another all Ala strand. Breaking down the interaction enthalpies into H-bonding and distortion energies shows the favorable interaction…

ONIOMOligopeptideAmyloidAmyloid010405 organic chemistryStereochemistryHydrogen bondChemistryNew ConceptHydrogen Bonding010402 general chemistry01 natural sciencesBiochemistryAcceptorProtein Structure Secondary0104 chemical sciencesProtein structureAmino Acid SubstitutionMutationPeptide bondThermodynamicsDensity functional theoryOligopeptidesBiochemistry
researchProduct

Nemo regulates cell dynamics and represses the expression of miple, a midkine/pleiotrophin cytokine, during ommatidial rotation

2013

AbstractOmmatidial rotation is one of the most important events for correct patterning of the Drosophila eye. Although several signaling pathways are involved in this process, few genes have been shown to specifically affect it. One of them is nemo (nmo), which encodes a MAP-like protein kinase that regulates the rate of rotation throughout the entire process, and serves as a link between core planar cell polarity (PCP) factors and the E-cadherin–β-catenin complex. To determine more precisely the role of nmo in ommatidial rotation, live-imaging analyses in nmo mutant and wild-type early pupal eye discs were performed. We demonstrate that ommatidial rotation is not a continuous process, and …

Ommatidial rotationRotationCellMutantEyePleiotrophinModels BiologicalArticleImaging Three-DimensionalmedicineAnimalsDrosophila ProteinsMipleProtein kinase AMolecular BiologyGenetic Association Studiesbeta CateninBody PatterningMidkineLive-imagingbiologyGene Expression ProfilingMidkineGene Expression Regulation DevelopmentalCell BiologyCadherinsPhenotypeMolecular biologyCell biologyDrosophila melanogasterPhenotypemedicine.anatomical_structureImaginal DiscsNemoMutationbiology.proteinCytokinesDrosophila eyeFemaleGene expressionMitogen-Activated Protein KinasesSignal transductionOmmatidial rotationDevelopmental BiologyDevelopmental Biology
researchProduct

Prognostic Impact of Mutant to Wild-Type Ratio and Insertion Site in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication

2012

Abstract Abstract 785 Background: FLT3 internal tandem duplications (FLT3-ITD) occur in about 25% of acute myeloid leukemia (AML), are associated with cooperating gene mutations (NPM1, DNMT3A), and confer an adverse prognosis. Several studies have indicated that the unfavorable impact of FLT3-ITD is influenced by a number of factors, such as the mutant to wild-type ratio (allelic ratio), insertion site of FLT3-ITD in the beta1 sheet of the tyrosine kinase domain 1, and the molecular background of cooperating mutations. Aims: To evaluate the relative impact of FLT3-ITD allelic ratio and insertion site, as well as cooperating genetic lesions on prognosis and treatment decision making in a lar…

OncologyAcute promyelocytic leukemiaFLT3 Internal Tandem Duplicationmedicine.medical_specialtyNPM1business.industrymedicine.medical_treatmentImmunologyMyeloid leukemiaCell BiologyHematologyHematopoietic stem cell transplantationGene mutationmedicine.diseaseBiochemistrySurgeryQuartilehemic and lymphatic diseasesInternal medicinemedicinebusinesspsychological phenomena and processesNeoadjuvant therapyBlood
researchProduct

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.

2021

Background Approvals of cancer therapeutics are primarily disease entity specific. Current molecular diagnostic approaches frequently identify actionable alterations in rare cancers or rare subtypes of common cancers for which the corresponding treatments are not approved and unavailable within clinical trials due to entity-related eligibility criteria. Access may be negotiated with health insurances. However, approval rates vary, and critical information required for a scientific evaluation of treatment-associated risks and benefits is not systematically collected. Thus clinical trials with optimized patient selection and comprehensive molecular characterization are essential for translati…

OncologyAdultCancer Researchmedicine.medical_specialtymedicine.medical_treatmentLocally advancedAntineoplastic AgentsPhosphatidylinositol 3-KinasesClinical Trials Phase II as TopicInternal medicineNeoplasmsClinical endpointMedicineHumansMulticenter Studies as TopicRisks and benefitsOriginal ResearchDisease entitybusiness.industrytarget therapyCancerImmunotherapymedicine.diseaseProgression-Free SurvivalClinical trialERBB2 AmplificationOncologyprecision oncologyMutationimmunotherapyclinical trial in progressbusinessESMO open
researchProduct